Biodel Inc. (NASDAQ:BIOD)
|
4.36 0.00 (0.00%) 3:19EST Delayed |
|
|
|
- Compare BIOD with:
- View: Line | Candlestick
Company Profile
Biodel Inc.
100 Saw Mill Road
Danbury, CT 06810
United States - Map
Phone: (203) 796-5000
Fax: (203) 796-5001
Website: www.biodel.com
CEO: Dr. Solomon S. Steiner, Ph.D.
Employees: 54
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
A specialty biopharmaceutical company
A specialty biopharmaceutical company, focused on the development and commercialization of innovative treatments for endocrine disorders such as diabetes.
Recent news for BIOD
-
BIODEL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
EDGAR Online - Mar 08 at 3:19PM (EST)
-
FDA to review Biodel diabetes drug candidate
AP - Mar 01 at 12:37PM (EST)
-
Taser, Ariad Pharmaceuticals: Early Volume Plays
TheStreet.com - Mar 01 at 10:04AM (EST)
-
UPDATE - Biodel says FDA accepts diabetes drug application
Reuters - Mar 01 at 8:53AM (EST)
-
- Mar 01 at 8:53AM (EST)
-
FDA Accepts VIAject® NDA for Review
Business Wire - Mar 01 at 7:00AM (EST)
-
InPlay: Biodel announces FDA Accepts VIAject NDA for Review
Briefing.com - Mar 01 at 7:00AM (EST)
-
Yale Endowment Narrowly Focused on ETFs, Selected Stocks
Indie Research - Feb 23 at 8:51AM (EST)
-
EDGAR Online Financials - Feb 11 at 1:04PM (EST)
-
Business Wire - Feb 11 at 7:00AM (EST)